People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | — | Pharmaceuticals | Series A | $15.0M | $464.6M | 2016 |
Keith C. Manchester at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Keith C. Manchester on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David C. Hastings | 1 | 2 |
| JAMES C. MEYERS | 1 | 2 |
| Andrew C. Cheng | 1 | 1 |
| Eric C. Venker | 1 | 1 |
| William H. Collier | 1 | 1 |
| Gaston J. Picchio | 1 | 1 |
| Michael J. McElhaugh | 1 | 1 |
| Frank J. Torti | 1 | 1 |
| Daniel J. Burgess | 1 | 1 |
| Michael J. Sofia | 1 | 1 |
| Elizabeth C. Howard | 1 | 1 |
| Tram C. Tran | 1 | 1 |
| Richard C. Henriques | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.